相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
Ayelet Avraham et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients
Thomas E. Liggett et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody et al.
BREAST CANCER RESEARCH (2011)
Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool
Y. H. Chia et al.
BRITISH JOURNAL OF CANCER (2010)
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
Gayatri Sharma et al.
LIFE SCIENCES (2010)
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients
Huizheng Bao et al.
ANTI-CANCER DRUGS (2008)
Epigenetic alterations of CDH1 and APC genes:: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast
Chandra P. Prasad et al.
LIFE SCIENCES (2008)
Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy
Oliver Riesterer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer
Dhafir Al-Azawi et al.
BMC CANCER (2006)
The basal phenotype of BRCA1-related breast cancer - Past, present and future
MD Tischkowitz et al.
CELL CYCLE (2006)
Detection of RASSF1A and RARβ Hypermethylation in Serum DNA from Breast Cancer Patients
Shruti Shukla et al.
EPIGENETICS (2006)
BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions
Ronit I. Yarden et al.
MOLECULAR CANCER THERAPEUTICS (2006)
New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines
DL Crowe et al.
BREAST CANCER RESEARCH (2006)
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
EK Baker et al.
ONCOGENE (2005)
Epigenetic regulation of WTH3 in primary and cultured drug-resistant breast cancer cells
KG Tian et al.
CANCER RESEARCH (2005)
Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials
EO Hanrahan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients
E Dulaimi et al.
CLINICAL CANCER RESEARCH (2004)
Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker
JM Teodoridis et al.
DRUG RESISTANCE UPDATES (2004)
The role of BRCA1 in the cellular response to chemotherapy
RD Kennedy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0)
SVS Deo et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
BRCA1 gene in breast cancer
EM Rosen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
E Evron et al.
LANCET (2001)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
